Retrospective Analysis of Patients Implanted With 2 Levels of Prodisc® C Vivo Devices

计划入组 200 人 · 首次发布于 2026 年 1 月 27 日

Clinical and Radiological Outcomes: Two-level Cervical ProDisc-C Vivo Versus Hybrid Construct.

计划入组 542 人 · 首次发布于 2017 年 12 月 8 日

A Multi-center Prospective Randomized Controlled Study on Clinical and Radiographic Analysis of ProDisc-C Vivo

计划入组 648 人 · 首次发布于 2017 年 12 月 8 日

Ex Vivo Expanded Allogeneic γδ T Cells therapy

Ex-vivo expanded allogeneic γδ T cell

C 135LS/C 144LS

C & C Oxygen Company

United States

IMPACTIV, INC.

United States

Buchanan C Michael

United States

Centinel Spine Achieves FDA Approval for Two-Level Cervical Disc Replacement with Record-Breaking Clinical Success Rate

Scribe Therapeutics' CRISPR Therapies Show Promise in Cardiometabolic Disease Treatment

In Vivo CAR T-Cell Therapies Advance to Clinical Trials, Promising Faster, Cheaper Cancer Treatment